The Loma Linda University Center for Health Disparities Research (LLU CHDR) was established by an EXPORT award from the NCMHD to develop new infrastructure for research in health disparities at LLU and the Inland Empire (IE) region of Southern California. The overall goal of this competitive renewal application is to support a successful enterprise that is already addressing health disparities in the IE. The four objectives of this application are: Objective 1: To enhance the research and administrative infrastructure of LLU to conduct competitive and sustainable research, training, education and outreach in health disparities. This objective will ensure having an efficient administrative infrastructure to support the center. Objective 2 is to build a successful enterprise in health disparities research leading to translational discoveries to reduce the burden of breast cancer, prostate cancer, and type 2 diabetes disparities. Innovative approaches to study gene-environmental interactions in type 2 diabetes in Mexican Americans, immunoseroproteomics profiling in African American men with prostate cancer, and triple negative breast cancer chemoreslstance in African American women, will lead the center to address these killer diseases that are disproportionately impacting underserved communities. Objective 3 is to sustain a comprehensive and robust pipeline of health disparities researchers from underrepresented and medically underserved populations. The center has identified a pool of hundreds of students from health disparities populations that have been participating in this successful program. Objective 4 is to engage with an established network of CBOs and LLU partnerships in addressing the problems of health disparities and to facilitate the translation of advances in breast cancer, prostate cancer and Type 2 diabetes to underserved communities. Fulfilling this objective will result in an army of trained and LLU certified """"""""Promotores"""""""" engaged in prevention education program to reduce the burden of health disparities diseases in this underserved region of California. Accomplishment of these objectives will make the LLU CHDR/CHDMM an established resource for excellence in research, training and successful partnership. .

Public Health Relevance

; This project has much public health relevance in that it will utilize multi-transdisciplinary research approaches and strategies to implement multi-level individual, population-based, and policy interventions to address health disparities, especially, as related to obesity, becoming a model in understanding and improving the health of minorities and underserved populations in Mississippi.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD006988-03
Application #
8609513
Study Section
Special Emphasis Panel (ZMD1-RN (01))
Program Officer
Tabor, Derrick C
Project Start
2012-07-01
Project End
2017-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
3
Fiscal Year
2014
Total Cost
$1,128,576
Indirect Cost
$396,573
Name
Loma Linda University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
009656273
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Cajigas-Du Ross, Christina K; Martinez, Shannalee R; Woods-Burnham, Leanne et al. (2018) RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget 9:30363-30384
Rowland, Leah K; Campbell, Petreena S; Mavingire, Nicole et al. (2018) Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death. J Cell Biochem :
Woods-Burnham, Leanne; Cajigas-Du Ross, Christina K; Love, Arthur et al. (2018) Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Sci Rep 8:15063
Woods-Burnham, Leanne; Stiel, Laura; Wilson, Colwick et al. (2018) Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. Am J Mens Health 12:751-759
Campbell, Petreena S; Mavingire, Nicole; Khan, Salma et al. (2018) AhR ligand aminoflavone suppresses ?6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. J Cell Physiol 234:108-121
Cordero, Kathia; Coronel, Gemma G; Serrano-Illán, Miguel et al. (2018) Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury. Brain Sci 8:
Greer-Phillips, Suzanne E; Sukomon, Nattakan; Chua, Teck Khiang et al. (2018) THE AER2 RECEPTOR FROM VIBRIO CHOLERAE IS A DUAL PAS-HEME OXYGEN SENSOR. Mol Microbiol :
Gonda, Amber; Kabagwira, Janviere; Senthil, Girish N et al. (2018) Exosomal survivin facilitates vesicle internalization. Oncotarget 9:34919-34934
Lewis, Charlotte M; Gamboa-Maldonado, Thelma; Carlos Belliard, Juan et al. (2018) Patient and Community Health Worker Perceptions of Community Health Worker Clinical Integration. J Community Health :
Descorbeth, Magda; Figueroa, Karen; Serrano-Illán, Miguel et al. (2018) Protective effect of docosahexaenoic acid on lipotoxicity-mediated cell death in Schwann cells: Implication of PI3K/AKT and mTORC2 pathways. Brain Behav 8:e01123

Showing the most recent 10 out of 106 publications